Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Liaoning Aoda Pharmaceutical Co., Ltd., established on 1996-12-13, Business scope includes licensed projects:pharmaceutical production,Food additive production,Power generation business,Transmission business,for(match)Electric business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Manufacturing of basic chemical raw materials(Manufacture of licensed chemicals free of hazardous chemicals),Food Additive Sales,Photovoltaic power generation equipment rental(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Hangzhou Sciwind Biosciences Co., Ltd. (doing business as Sciwind) is a Chinese company located in Hangzhou. The firm engages in research and development of biological drugs. It was founded in 2017 by Hai Pan, who has been the CEO since that date.\nThe company says this about itself: Sciwind Biosciences is a clinical stage biopharmaceutical company focusing on discovering and developing innovative therapies to treat metabolic disease. Its product pipeline consists of potentially first-in-class and best-in-class drug candidates, including the long-acting GLP-1 peptide analog ecnoglutide (Phase 3), oral GLP-1 peptide analog XW004 (Phase 1), and oral small molecule GLP-1 receptor agonist XW014 (Phase 1). Sciwind has developed multiple proprietary technologies, including oral peptide and inhaled protein therapeutic delivery platforms and identified a series of drug candidates based on these core platform technologies.

Centre Hospitalier de lUniversite de Montreal owns and operates general hospitals. The firm provides inpatient and ambulatory care to its immediate urban clientele and specialized & ultra specialized services. The company was founded in 1995 and is headquartered in Montreal, Canada.

Biocrine’s goal is to commercialize new concepts of treatment and enable continual delivery of novel drugs both for diabetes itself and for the complications that this disease induces.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing, and R&D company.

Shanghai Yinnuo Biomedical Engineering Co., Ltd., established on 2020-12-22, Business scope includes general items:engaged in biotechnology,Technical services in the field of medical technology,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(human stem cells,Except for the development and application of genetic diagnosis and treatment technology);Chemical product sales(No licensed chemical products);Import and export;Technology Import and Export;Health Consulting Services(Does not include medical services);Engineering and Technology Research and Experimental Development(human stem cells,Except for the development and application of genetic diagnosis and treatment technology,Research and development of rare and unique precious varieties in China,farming,Planting and production of related propagating material(including farming,animal husbandry,Good Genes of Aquaculture)except);Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology);Sales of Class II Medical Devices;Sales of Class I Medical Devices;Production of Class I Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:pharmaceutical production;Pharmaceutical commissioned production;Drug retail;Drug Wholesale;Drug import and export;Drug internet information service;Class III medical device business;Production of Class III Medical Devices;Production of Class II Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Wuhan Institute of Biotechnology

Shanghai Gurney Biotechnology Co., Ltd., established on 2009-12-07, The scope of business includes technical consultation in the field of biological expertise,Technical Services,technology development,technology transfer,Business Consulting(In addition to brokerage),Chemical product sales(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),Engaged in the import and export of goods and technology.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Wuhan Bio-Pharmaceutical Co., Ltd., established on 2011-10-12, Business scope includes drug research and development;Biotechnology product development;technical consulting,technology transfer,Technical Services.(In the above-mentioned scope of business, the projects with special provisions of the state shall be operated within the approved period after approval or with the license)

Kunming Yinnuo Pharmaceutical Technology Co., Ltd. engages in the manufacture of pharmaceutical products and medical devices. The company was founded on December 5, 2014 and is headquartered in Kunming, China.

Milliken & Company is a diversified industrial manufacturer that has been in business since 1865. With corporate headquarters located in Spartanburg, South Carolina, the company is active across a breadth of disciplines including specialty chemical, floor covering,, performance and protective textile materials, and healthcare.

Dong Wha Pharm Co., Ltd. engages in the manufacture and sale of pharmaceuticals and medicinal chemicals. Its products include medicines for digestion, skin scars, general cold, gum treatment, high blood pressure, infection, gastrointestinal tract control, and others. The company was founded on September 25, 1897 and is headquartered in Seoul, South Korea.